Ad/HER2/Neu dendritic cell cancer vaccine

· National Cancer Institute (NCI)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Ad/HER2/Neu dendritic cell cancer vaccine, covering 2022-09-10 to 2022-09-10. Get the full timeline:

Most recent: Clinical Trial Update: Ad/HER2/Neu Dendritic Cell Cancer Vaccine Testing [Phase 1]